DE69420401D1 - Anästhetikum in aerosolform auf der basis von lidocain - Google Patents

Anästhetikum in aerosolform auf der basis von lidocain

Info

Publication number
DE69420401D1
DE69420401D1 DE69420401T DE69420401T DE69420401D1 DE 69420401 D1 DE69420401 D1 DE 69420401D1 DE 69420401 T DE69420401 T DE 69420401T DE 69420401 T DE69420401 T DE 69420401T DE 69420401 D1 DE69420401 D1 DE 69420401D1
Authority
DE
Germany
Prior art keywords
anaesthetic
airway
hfc
lidocaine
local
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69420401T
Other languages
English (en)
Other versions
DE69420401T2 (de
Inventor
Richard A Henry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HENRY, RICHARD A., DR., KINGSTON, ONTARIO, CA
Original Assignee
LYNCHRIS PHARM Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LYNCHRIS PHARM Ltd filed Critical LYNCHRIS PHARM Ltd
Publication of DE69420401D1 publication Critical patent/DE69420401D1/de
Application granted granted Critical
Publication of DE69420401T2 publication Critical patent/DE69420401T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE69420401T 1993-03-29 1994-03-28 Anästhetikum in aerosolform auf der basis von lidocain Expired - Lifetime DE69420401T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3893093A 1993-03-29 1993-03-29
PCT/CA1994/000159 WO1994022422A1 (en) 1993-03-29 1994-03-28 Lidocaine aerosol anaesthetic

Publications (2)

Publication Number Publication Date
DE69420401D1 true DE69420401D1 (de) 1999-10-07
DE69420401T2 DE69420401T2 (de) 2000-05-04

Family

ID=21902722

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69420401T Expired - Lifetime DE69420401T2 (de) 1993-03-29 1994-03-28 Anästhetikum in aerosolform auf der basis von lidocain

Country Status (8)

Country Link
EP (1) EP0691842B1 (de)
JP (1) JP3618346B2 (de)
AT (1) ATE183919T1 (de)
AU (1) AU676025B2 (de)
CA (1) CA2156821C (de)
DE (1) DE69420401T2 (de)
ES (1) ES2138074T3 (de)
WO (1) WO1994022422A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
JPH10510198A (ja) * 1995-05-12 1998-10-06 ジェネンテク・インコーポレイテッド 機能生物学的物質の粗いスプレー供給
WO2009035646A1 (en) 2007-09-12 2009-03-19 Wolfe Tory Medical, Inc. Applicator for oropharyngeal anesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
GB9103302D0 (en) * 1991-02-16 1991-04-03 Smithkline Beecham Plc Pharmaceutical formulations
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations

Also Published As

Publication number Publication date
CA2156821A1 (en) 1994-10-13
WO1994022422A1 (en) 1994-10-13
EP0691842B1 (de) 1999-09-01
ATE183919T1 (de) 1999-09-15
CA2156821C (en) 2005-02-15
AU6256294A (en) 1994-10-24
JPH08511767A (ja) 1996-12-10
AU676025B2 (en) 1997-02-27
DE69420401T2 (de) 2000-05-04
JP3618346B2 (ja) 2005-02-09
EP0691842A1 (de) 1996-01-17
ES2138074T3 (es) 2000-01-01

Similar Documents

Publication Publication Date Title
DK0616525T3 (da) Medikamenter
NZ243061A (en) Aerosol containing a medicament and 1,1,1,2,3,3,3-heptafluoropropane
RU94040361A (ru) Аэрозольная фармацевтическая композиция, баллончик для доставки композиции, дозировочный ингалятор, способ лечения респираторных заболеваний, способ получения композиции
KR960700689A (ko) 디올-디산계 분산 보조제를 함유하는 분무 제제(aerosol formulation containing a diol-diacid derived dispersing aid)
AU4260496A (en) Propellant mixture for aerosol formulation
GB2288978B (en) Hydrocarbon inhalant solutions stabilised by organic or inorganic acids
NZ334149A (en) Pharmaceutical aerosol composition containing an active material, a propellant containing a hydrofluoroalkane and a cosolvent and a low volatility component
BR9307141A (pt) Processo para a liberação sistência pulsátil de um fragmento ativo de hormônio de paratiróide (PTH) para um hospedeiro mamífero e para um paciente e composição farmacêutica
NO993773L (no) Medisinske aerosolformuleringer
MY108748A (en) Medicaments
MY108564A (en) Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
US5593661A (en) Lidocaine aerosol anaesthetic
IL153726A0 (en) Novel aerosol formulation containing a polar fluorinated molecule
HUP9902675A2 (hu) Fluorozott-szénhidrogén-hajtógázt tartalmazó mometazon-furoát aeroszol
DE69420401D1 (de) Anästhetikum in aerosolform auf der basis von lidocain
WO1999024016A8 (en) Emulsions for aerosolization and drug delivery
EP1110547A3 (de) Helium und Neon als Hilfsstoffe zur Wirkstoffverabreichung mittels Inhalator

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HENRY, RICHARD A., DR., KINGSTON, ONTARIO, CA